TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
GENB

Generate Biomedicines, Inc.

Healthcare · Biotechnology

16.00$ -3.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow GENB
Line item 2024 2025
– –
– -14.1%
– +5.7%
– -152.0%
– +1.9%
– –
– -26.6%
– -69.3%
– –
– –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?